Edit

GSK

A visualisation of a membraneless organelle in the green-yellow style of the data presented in the Nature Communications paper

ATP affects proteome-wide solubility

Scientists develop technology to measure how ATP concentration affects protein solubility in…

By Josh Tapley

Science

Takeda logo on white background

Takeda joins drug target discovery initiative

Takeda joins pioneering public-private drug discover collaboration Open…

By Oana Stroe

Lab Matters

UK-based EMBL alumni gather at Trinity Hall, Cambridge in May 2016. PHOTO: Robert Slowley

Making business in Britain

Abel Ureta-Vidal and Louise Modis join colleagues and peers at gathering of UK-based…

By Mary Todd Bergman

Alumni

Biogen joins the CTTV

Biogen joins CTTV

Pioneering target validation collaboration expands to accelerate drug discovery…

By Mary Todd Bergman

Lab Matters

New web interface, launched by GSK, EMBL-EBI and Wellcome Trust Sanger Institute.

Target Validation platform launches

Identifying evidence-based relationships between drug targets and…

By Mary Todd Bergman

Lab Matters

Riccardo Cortese, former head of the Genome Biology Unit

Inside industry: Part I

Career insights from Riccardo Cortese, whose start-up is developing an Ebola vaccine…

By Guest author(s)

Alumni

Inside industry: Part II

Alumni in senior positions in industry share career challenges, highlights and EMBL’s continuing…

By Guest author(s)

Alumni

Dr Jeffrey Barrett

Jeffrey Barrett to lead CTTV

Jeffrey Barrett appointed Director of CTTV, the GSK, EMBL-EBI and Sanger Institute…

By Mary Todd Bergman

Lab Matters

On target

A new EMBL-EBI biomedical initiative works to determine the best target proteins for new…

By Mary Todd Bergman

Lab Matters

EMBLetc.

Read the latest Issues of our magazine - EMBLetc.

Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.

EMBLetc. archive

Newsletter archive

Read past editions of our monthly e-newsletter

For press

Contact the Press Office
Edit